Position in MRNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,733
+$68,047 QoQ
Shares Held
1,110
+196.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#525
of 758 holders
Holding Since
Dec 2021
9 quarters on record
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ameritas Advisory Services, LLC holds $690,036 across 47 Biotechnology names. MRNA ranks #2 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
337 | $167,398 | |
| 2 | MRNA |
Moderna, Inc.
This page
|
1,110 | $77,733 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119 | $74,201 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,018 | $55,521 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
256 | $47,943 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
193 | $46,507 | |
| 7 | FATE |
Fate Therapeutics Inc
|
16,000 | $43,200 | |
| 8 | VCEL |
Vericel Corp
|
818 | $36,392 |
All Filings in MRNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,733 | 1,110 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $9,686 | 375 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $18,733 | 679 | Shares | Sole | 2025-07-21 | |
| 2023-03-31 | $175,388 | 1,142 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $369,478 | 2,057 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $203,981 | 1,725 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $315,555 | 2,209 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $324,193 | 1,882 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $501,102 | 1,973 | Shares | Sole | 2022-02-07 | |
| No filing history on record for this holder in this stock. | ||||||